References
- Piriou ER, van Dort K, Nanlohy NM, Miedema F, van Oers MH, van Baarle D. Altered EBV viral load setpoint after HIV seroconversion is in accordance with lack of predictive value of EBV load for the occurrence of AIDS-related non- Hodgkin lymphoma. J Immunol 2004;172:6931–7.
- Ernberg I. The role of Epstein–Barr virus in lymphomas of homosexual males. Prog Allergy 1986;37:301–18.
- Piriou E, van Dort K, Otto S, van Oers MH, van Baarle D. Tight regulation of the Epstein–Barr virus setpoint: interindividual differences in Epstein–Barr virus DNA load are conserved after HIV infection. Clin Infect Dis 2008;46: 313–6.
- Gaidano G, Dalla-Favera R. Molecular pathogenesis of AIDS-related lymphomas. Adv Cancer Res 1995;67:113–53.
- Camilleri-Broët S, Davi F, Feuillard J, Bourgeois C, Seilhean D, Hauw JJ, . High expression of latent membrane protein 1 of Epstein–Barr virus and BCL-2 oncoprotein in acquired immunodeficiency syndrome-related primary brain lymphomas. Blood 1995;86:432–5.
- Palmieri C, Treibel T, Large O, Bower M. AIDS-related non-Hodgkin's lymphoma in the first decade of highly active antiretroviral therapy. QJM 2006;99:811–26.
- Simard EP, Pfeiffer RM, Engels EA. Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States. Cancer 2011;5:1089–96.
- Huhn G, Badri S, Vibhakar S, Tverdek F, Crank C, Lubelchek R, . Early development of non-Hodgkin lymphoma following initiation of newer class antiretroviral therapy among HIV-infected patients—implications for immune reconstitution. AIDS Res Ther 2010;7:44–52.
- Lindbäck S, Broström C, Karlsson A, Gaines H. Does symptomatic primary HIV-1 infection accelerate progression to CDC stage IV disease, CD4 count below 200 × 10(6)/l, AIDS, and death from AIDS? BMJ 1994;309:1535–7.
- Broström C, Comandini UV, Yun Z, Sönnerborg A. Longitudinal quantification of human immunodeficiency virus type 1 DNA and RNA in long-term nonprogressors. J Infect Dis 1999;179:1542–8.
- Sandström E, Wahren B. Therapeutic immunisation with recombinant gp160 in HIV-1 infection: a randomised double-blind placebo-controlled trial. Nordic VAC-04 Study Group. Lancet 1999;353:1735–42.
- Friis AM, Gyllensten K, Aleman A, Ernberg I, Åkerlund B. The effect of antiretroviral combination treatment on Epstein–Barr virus (EBV) genome load in HIV-infected patients. Viruses 2010;2:867–79.
- Gustafsson A, Levitsky V, Zou JZ, Frisan T, Dalianis T, Ljungman P, . Epstein–Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells. Blood 2000;95:807–14.
- Streeck H, Nixon DF. T cell immunity in acute HIV-1 infection. J Infect Dis 2010;202(Suppl 2):S302–8.
- Bekker V, Scherpbier H, Pajkrt D, Jurriaans S, Zaaijer H, Kuijpers TW. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection. Pediatrics 2006; 118:315–22.
- Haynes BF, Moody MA, Liao HX, Verkoczy L, Tomaras GD. B cell responses to HIV-1 infection and vaccination: pathways to preventing infection. Trend Mol Med 2011;17:108–16.
- Richard Y, Amiel C, Jeantils V, Mestivier D, Portier A, Dhello G, . Changes in blood B cell phenotypes and Epstein–Barr virus load in chronically human immunodeficiency virus-infected patients before and after antiretroviral therapy. J Infect Dis 2010;202:1424–34.
- Webster A, Phillips AN, Lee CA, Janossy G, Kernoff PB, Griffiths PD. Cytomegalovirus (CMV) infection, CD4 + lymphocyte counts and the development of AIDS in HIV- 1-infected haemophiliac patients. Clin Exp Immunol 1992; 88:6–9.
- Curry M, Golden-Mason L, Doherty DG, Deignan T, Norris S, Duffy M, . Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liver. J Hepatol 2003;38:642–50.
- Schöllkopf C, Smedby KE, Hjalgrim H, Rostgaard K, Panum I, Vinner L, . Hepatitis C infection and risk of malignant lymphoma. Int J Cancer 2008;122:1885–90.